A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma

Madeleine Duvic, Elise A. Olsen, George A. Omura, John C. Maize, Eric C. Vonderheid, Craig A. Elmets, Jerome L. Shupack, Marie France Demierre, Timothy M. Kuzel, Deborah Y. Sanders

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences